Biocon to merge biologics unit; to acquire stake held by Serum, Mylan

Biocon will acquire the remaining stake in Biocon Biologics Limited through a share swap, valuing Biocon Biologics at $5.5 billion

Dec 6, 2025 - 18:00
 0  5
Biocon to merge biologics unit; to acquire stake held by Serum, Mylan
Biocon will acquire the remaining stake in Biocon Biologics Limited through a share swap, valuing Biocon Biologics at $5.5 billion

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow